Table 3. Postoperative morbidity and mortality.
| Chylothoraxa | No Chylothoraxa | p-value | |
|---|---|---|---|
| Any Major Complicationb (n, %) | 29 (85%) | 395 (46%) | <0.001 |
| Pneumonia | 10 (29%) | 107 (14%) | 0.009 |
| Reintubation | 13 (39%) | 143 (18%) | 0.002 |
| Empyema | 3 (9%) | 57 (7%) | 0.724 |
| Acute Respiratory Distress Syndrome | 5 (15%) | 26 (3%) | 0.001 |
| Renal failure | 4 (12%) | 55 (7%) | 0.279 |
| Sepsis | 8 (24%) | 62 (8%) | 0.001 |
| Septic Shock Req. Vasopressors | 6 (18%) | 27 (3%) | <0.001 |
| Clinically significant anastomotic leakc | 5 (15%) | 82 (10%) | 0.407 |
| Gastric tube necrosis | 0 (0%) | 21 (3%) | 0.342 |
|
| |||
| Length of initial postoperative hospital stay (median, IQR) | 17 (12-27) | 8 (6-16) | 0.005 |
| Readmission within 30 days | 10 (29%) | 139 (18%) | 0.092 |
| Reoperation in-hospital or within 30 days | 23 (68%) | 133 (17%) | <0.001 |
|
| |||
| In-hospital or 30-day mortalityd | 6 (17.7%) | 33 (3.9%) | <0.001 |
| Mortality within 90 days | 8 (24%) | 62 (7%) | 0.001 |
a
Not all criteria were in the record and able to be abstracted for every patient; reported % are based on total patients for whom the criteria was recorded
b
Morbidity defined according to the Society of Thoracic Surgery General Thoracic Surgery Database definitions
c
Clinically significant leak includes all patients requiring either neck drainage, endoscopic drain manipulation or reoperation with intrathoracic drainage.
d
Mortality determined using chart review and Social Security Death Index